Puramed Bioscience Inc. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months
Puramed Bioscience Inc. had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $6.36 thousand as of 2014-06-30, per its 10-K filed 2014-10-14.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2014-10-14
- 2014-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $6.36K.
- 2013-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $5.86K.
- 2012-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $48.01K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months |
|---|---|
| 2014-06-30 | $6.36K 10-K · filed 2014-10-14 |
| 2013-06-30 | $5.86K 10-K · filed 2013-10-15 |
| 2012-06-30 | $48.01K 10-K · filed 2012-10-12 |